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technology related to TMJ disorders. These collective multidisciplinary interactions over the past decade
have made large strides in moving the field of TMJ research forward. Over the past 12 years, in vivo
approaches for tissue engineering have emerged, along with a wide variety of degeneration models, as well
as with models occurring in nature. Furthermore, biomechanical tools have become more sensitive and
new biologic interventions for disease are being developed. Clinical directives have evolved for specific
diagnoses, along with patient-specific biological and immunological responses to TMJ replacement devices
alloplastic and/or bioengineered devices. The 6th TMJBC heralded many opportunities for funding
agencies to advance the field: 1) initiatives on TMJ that go beyond pain research, 2) more training
grants focused on graduate students and fellows, 3) partnership funding with government agencies to
translate TMJ solutions, and 4) the recruitment of a critical mass of TMJ experts to participate on
grant review panels. The TMJ research community continues to grow and has become a pillar of dental
and craniofacial research, and together we share the unified vision to ultimately improve diagnoses and
treatment outcomes in patients affected by TMJ disorders.
DOI: https://doi.org/10.1115/1.4044090





Almarza, Alejandro; Mercuri, Louis; Arzi, Boaz; Gallo, Luigi M; Granquist, Eric; Kapila, Sunil; De-
tamore, Michael (2020). State of TMJ Bioengineering: Working Together Toward Improving Clinical
Outcomes. Journal of Biomechanical Engineering, 142(2):020801.
DOI: https://doi.org/10.1115/1.4044090
Journal of Biomechanical Engineering 
Copy of e-mail Notification
Journal of Biomechanical Engineering Published by ASME
 
Dear Author,
Congratulations on having your paper accepted for publication in the ASME Journal Program.
Your page proof is available from the ASME Proof site here:
http://cps.kwglobal.com/MIS/AuthorProofLogin.aspx?pwd=0c102573e094&CA=AS
 
Login: your e-mail address
Password: 0c102573e094
 
Please keep this email in case you need to refer back to it in the future.
Responsibility of detecting errors rests with the author. Please review the page proofs carefully and:
1. Answer any queries on the “Author Query Form”
2. Proofread any tables and equations carefully
3. Check to see that any special characters have translated correctly
4. Publication will not proceed until a response is received. If there are no corrections, a response is still required.
 
RETURNING CORRECTIONS:
Corrections must be returned using the ASME Proof Download & Corrections Submission Site (link above). You
will be able to upload:
1. Annotated PDF
2. Text entry of corrections, with line numbers, in the text box provided
3. Additional files, if necessary.
 
SPECIAL NOTES:
Your Login and Password are valid for a limited time. Please reply within 48 hours.
 
Corrections not returned through the above website will be subject to publication delays.
This e-proof is to be used only for the purpose of returning corrections to the publisher. Please note, the figures in
this proof are low resolution, the final paper will publish with all figures as 300 dpi. If you have any questions,
please contact:  asme.cenveo@cenveo.com, and include your article no. (BIO-19-1034) in the subject line. This
email should not be used to return corrections.
 
Approval of these proofs re-confirms the copyright agreement provision that all necessary rights from third parties
for any copyrighted material (including without limitation any diagrams, photographs, figures or text) contained in
the paper has been obtained in writing and that appropriate credit has been included.
 
Sincerely,
Mary O'Brien, Journal Production Manager
STATEM ENT OF EDITORIAL POLICY AND PRACTICE 
  
 The Technical Commit tee on Publicat ions and Communicat ions (TCPC) of ASM E 
aims to maintain a high degree of technical, literary, and typographical excellence in its 
publicat ions.  Primary considerat ion in conduct ing the publicat ions is therefore given to 
the interests of the reader and to safeguarding the prest ige of the Society. 
  
 To this end the TCPC confident ly expects that  sponsor groups will subject  every 
paper recommended by them for publicat ion to careful and crit ical review for the 
purpose of eliminat ing and correct ing errors and suggest ing ways in which the paper 
may be improved as to clarity and conciseness of expression, accuracy of statement , and 
omission of unnecessary and irrelevant  material.  The primary responsibilit y for the 
technical quality of the papers rests with the sponsor groups. 
  
 In approving a paper for publicat ion, however, the TCPC reserves the right  to 
submit  it  for further review to competent  crit ics of its own choosing if  it  feels that  this 
addit ional precaut ion is desirable.  The TCPC also reserves the right  to request  revision 
or condensat ion of a paper by the author or by the staff for approval by the author.  It  
reserves the right , and charges the edit orial staff, to eliminate or modify statements in 
the paper that  appear to be not  in good taste and hence likely to offend readers (such as 
obvious advert ising of commercial ventures and products, comments on the intent ions, 
character, or acts of persons and organizat ions that  may be const rued as offensive or 
libelous), and t o suggest  to authors rephrasing of sentences where this will be in the 
interest  of clarity.  Such rephrasing is kept  to a minimum. 
  
 Inasmuch as specific criteria for the judging of individual cases cannot , in the 
opinion of the TCPC, be set  up in any but  the most  general rules, the TCPC relies upon 
the editorial staff to exercise its judgment  in making changes in manuscripts, in 
rearranging and condensing papers, and in making suggest ions to authors.  The TCPC 
realizes that  the opinions of author and editor may somet imes differ, and hence it  is an 
invariable pract ice that  no paper is published unt il it  has been passed on by the author.  
For this purpose page proofs of the edited paper are sent  to the author prior to 
publicat ion in a journal. Changes in content  and form made in the proofs by authors are 
followed by the editor except  in cases in which the Society’s standard spelling and 
abbreviat ion forms are affected. 
  
 If important  differences of opinion arise between author and editor, the points 
at  issue are discussed in correspondence or interview, and if  a solut ion sat isfactory to 
both author and editor is not  reached, the mat ter is laid before the TCPC for 
adjustment . 
  
Technical Commit tee on Publicat ions and Communicat ions (TCPC) 
Reviewed: 05/ 2012 
 
AUTHOR QUERY FORM
Journal: J. Biomech. Eng.
Article Number: BIO-19-1034
Please provide your responses and any corrections by
annotating this PDF and uploading it to ASME’s eProof
website as detailed in the Welcome email.
Dear Author,
Below are the queries associated with your article; please answer all of these queries before sending the proof back to




Query / Remark: click on the Q link to navigate
to the appropriate spot in the proof. There, insert your comments as a PDF annotation.
AQ1 Reminder – the ASME Copyright Agreement that was signed by all authors includes the following: “You have the right to
enter into this Copyright Form and to make the assignment of rights to ASME. If the Paper contains excerpts from other
copyrighted material (including without limitation any diagrams, photographs, figures or text), you have acquired in
writing all necessary rights from third parties to include those materials in the Paper, and have provided appropriate credit
for that third-party material in footnotes or in a bibliography.” As required, ASME may contact the authors to obtain a copy
of the written permission.
AQ2 Any content obtained from the web and included in the paper may require written permission and appropriate credit if it is
copyrighted content. If copyright status cannot be determined, this content should not be included in the paper.
AQ3 Please note the figures in this proof are low resolution, the final paper will publish with all figures as 300 dpi.
AQ4 The title provided in the author submission form is not the same title provided in the text of the paper. The title provided in the
text of the paper was used. Please check and revise the title if changes need to be made and also as per journal style, three or
fewer letters acronyms are not allowed in the title; therefore, we have replaced the acronym TMJ with the spelled out
definition.
AQ5 There is a discrepancy between the submitted manuscript and the metadata provided for author names. The names from the
manuscript have been used on this proof. Please review the author byline for accuracy and provide revisions as needed.
AQ6 Please provide zip code for the affiliation of the author “Boaz Arzi.”
AQ7 Please provide city name for the affiliation of the author “Luigi M. Gallo.”
AQ8 In the sentence beginning “The following sections. . ..” Please specify which sections or subsections “The following sections”
refer to here.
AQ9 Please define PGA and PLA at first occurrence.
AQ10 Figure 3 was not cited in text. Please check its insertion here.
AQ11 Please provide location (city and state/country) for Refs. 4 and 8.
AQ12 Please provide volume number and page range for Ref. 17.
AQ13 Please provide the year of publication, publisher name, location (city, state, and country), and last accessed date for Refs. 30.
AQ14 Please check the page range for Ref. 40.
AQ15 Please check the page range for Refs. 55 and 56.
AQ16 Please provide DOI or website to access article for Ref(s). 18, 22, 39, 42, 47, 48.





1 Alejandro J. Almarza1AQ5
2 Departments of Oral Biology and Bioengineering,
3 Center for Craniofacial Regeneration,
4 McGowan Institute of Regenerative Medicine,
5 University of Pittsburgh,
6 Pittsburgh, PA 15213
7 e-mail: aja19@pitt.edu
8 Louis G. Mercuri
9 Visiting Professor
10 Department of Orthopedic Surgery,
11 Rush University Medical Center,
12 Chicago, IL 60612;
13 TMJ Concepts,
14 Ventura, CA 93003
15 Boaz ArziAQ6
16 Department of Surgical and
17 Radiological Sciences,
18 School of Veterinary Medicine,
19 University of California,
20 Davis, CA
21 Luigi M. GalloAQ7
22 Clinic of Masticatory Disorders,
23 Center of Dental Medicine,
24 University of Zurich,
25 Zurich CH-8031, Switzerland
26 Eric Granquist
27 Department of Oral and Maxillofacial Surgery,
28 University of Pennsylvania,
29 Philadelphia, PA 19104
30 Sunil Kapila
31 Department of Orofacial Sciences,
32 School of Dentistry,
33 University of California San Francisco,
34 San Francisco, CA 94143
35 Michael S. Detamore
36 Stephenson School of Biomedical Engineering,
37 The University of Oklahoma,




Improving Clinical OutcomesAQ4 39
40 The sixth temporomandibular joint (TMJ) Bioengineering Conference (TMJBC) was held
on June 14–15 2018, in Redondo Beach, California, 12 years after the first TMJBC.
Speakers gave 30 presentations and came from the United States, Europe, Asia, and Aus-
tralia. The goal of the conference has remained to foster a continuing forum for bioengi-
neers, scientists, and surgeons and veterinarians to advance technology related to TMJ
disorders. These collective multidisciplinary interactions over the past decade have made
large strides in moving the field of TMJ research forward. Over the past 12 years, in vivo
approaches for tissue engineering have emerged, along with a wide variety of degenera-
tion models, as well as with models occurring in nature. Furthermore, biomechanical
tools have become more sensitive and new biologic interventions for disease are being
developed. Clinical directives have evolved for specific diagnoses, along with patient-
specific biological and immunological responses to TMJ replacement devices alloplastic
and/or bioengineered devices. The sixth TMJBC heralded many opportunities for funding
agencies to advance the field: (1) initiatives on TMJ that go beyond pain research, (2)
more training grants focused on graduate students and fellows, (3) partnership funding
with government agencies to translate TMJ solutions, and (4) the recruitment of a critical
mass of TMJ experts to participate on grant review panels. The TMJ research community
continues to grow and has become a pillar of dental and craniofacial research, and
together we share the unified vision to ultimately improve diagnoses and treatment out-
comes in patients affected by TMJ disorders. [DOI: 10.1115/1.4044090]
41 Introduction
42 A dozen years after the first temporomandibular joint (TMJ)
43 Bioengineering Conference (TMJBC) [1], the TMJ, or jaw joint,
44 the number of publications have risen (Fig. 1), yet there is still a
45 lack novel diagnostic tools or clinical therapies. The main symp-
46 tom that leads TMJ patients to seek medical treatment continues
47 to be pain or jaw dysfunction [2–4]. In terms of TMJ research
48 integration with other fields of science, there is still a lack of a
49 strong presence in either the dental or orthopedic fields. The
50 American Association of Dental Research (AADR) and the Inter-
51 national Association of Dental Research (IADR) both feature
52 TMJ research in a sporadic and diffuse manner, spread over dif-
53 ferent research groups. Moreover, the representation of TMJ
54 research in the Orthopedic Research Society (ORS) is even
55 sparser than at the AADR or IADR. Hence, there is an opportunity
56 to promote concentrated/dedicated sessions for TMJ research.
57Therefore, one of the continuing missions of the TMJBC has been
58to unite TMJ clinician, veterinarian, engineer, and biologist
59researchers across disciplines to increase the visibility of the TMJ
60field.
61The format of the TMJBC meeting has evolved from the first to
62the most recent sixth event2. The first conference in 2006 was
63funded by the National Institute of Dental and Craniofacial
64Research (NIDCR), with an extensive list of invited speakers
65documented in a 2007 publication in the Annals of Biomedical
66Engineering [1]. At the sixth TMJBC, speakers were selected
67from unsolicited abstracts and were then assigned a 15-min oral
68podium presentation. Presentations at the sixth TMJBC were
69organized into six areas of emphasis: Clinical studies, biome-
70chanics, natural occurring TMJ disorders in animals, animal mod-
71els of degeneration, biological basis for disease and treatments,
72and tissue engineering. There was time for group discussion of
73each topic, leading to general consensus on the cutting edge of
74technologies, gaps in the research, and the need for more
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75 standardized clinical and research approaches to the diagnosis and
76 management of TMJ disorders.
77 The objectives of this publication are to provide an overview
78 of the last conference, to highlight changes in the landscape of
79 publications/grants since the first TMJBC, to attract new talent
80 and established investigators to the field, and to call for policy
81 advancements to grow the TMJ research community. The follow-
82 ing sections will summarize the presentations for each area of
83 emphasis and indicate where further advances or greater focus is
84 required.AQ8
85 Clinical Studies Session
86 The clinical directives that emerged from the five prior
87 TMJBCs have matured. The TMJBCs have been influential in
88 moving surgeons toward a more orthopedic approach to the diag-
89 nosis and management of intra-articular TMJ pathology. This
90 orthopedic influence is not only reflected in the abstract presenta-
91 tions at recent TMJBC meetings but also additionally in a contem-
92 porary publication entitled “potential indications for tissue
93 engineering in temporomandibular joint surgery” [5] in which the
94 authors, utilizing both their basic science and clinical expertise,
95 developed patient inclusion and exclusion criteria for partial and
96 total TMJ reconstruction using bioengineered tissue.
97 The following is a synopsis of the clinically related presenta-
98 tions, followed by potential clinical directives that can be drawn
99 from them.
100 Alloplastic Temporomandibular Joint Replacement. The
101 sixth TMJBC demonstrated the continued expansion of surgeon
102 mindset to include an evidence-based approach to the manage-
103 ment of TMJ disorders. This migration was particularly evident in
104 presentations related to the management of end-stage TMJ dis-
105 ease, with the dissemination of preliminary results using three
106 new alloplastic total TMJ replacement systems from Australia,
107 Brazil, and India.
108 The Australian TMJ replacement system, from Dr. Dimitroulis’
109 group, utilizes a 3D-printed device with a custom-made direct
110 metal laser sintered metal alloy condyle, all polymer digitally
111 sized glenoid fossa, and custom surgical cutting and placement
112 guides. This device was tested in a cohort study in 38 patients,
113 with the longest follow-up reported to be 24months (mean
114 15.3months) [6].
115 The Brazilian TMJ device, from Dr. Genovesi’s group, is an
116 injection-molded TMJ replacement composed of a petroleum-
117 based material: polyether ether ketone (PEEK) LT1 20% Ba.
118 PEEK screws are used to fixate the fossa and short ramus compo-
119 nent to the host bone. To date, seven cases at 100 days were
120 reported.
121 The Indian selective laser melting (SLM), 3D printed, patient-
122 specific TMJ device was reported, by Dr. Mehrotra, to have been
123developed for the management of TMJ ankylosis and pathology.
124The fossa component is all-ultrahigh molecular weight polyethyl-
125ene and the condyle/ramus component was SLM 3D printed tita-
126nium alloy. Diet and quality of life variables were improved
127within 3months in the patient population reported.
128Although presentations at the TMJBC were not all peer-
129reviewed, the aforementioned presentations emphasize the global
130need and opportunity for forward-thinking approaches to TMJ
131total joint replacement, with lessons of the past [1,5] being
132increasingly more important as the opportunities for clinical trans-
133lation become within reach with varying regulatory frameworks
134worldwide.
135Biologic and Immunologic Reponses to Temporomandibu-
136lar Joint Replacement Materials. The potential biologic
137responses to material wear from alloplastic devices were
138described in a presentation by Dr. Mercuri, who reported serum
139metal levels in some maxillofacial reconstruction patients who
140had undergone dental implant placement, orthognathic surgery
141using rigid metal fixation plates and screws, or total alloplastic
142temporomandibular joint replacement. All control participants had
143levels below the normal reference range for all serum markers
144assessed. In the orthognathic group, one patient had an increased
145serum cobalt level. In the TMJ TJR group, one patient had an
146increased serum cobalt level and another patient had an increased
147serum chromium level. In the dental implant group, one patient
148had an increased serum titanium level and another had increased
149serum levels of titanium and chromium. The results raise ques-
150tions regarding the types and magnitude of metal released from
151maxillofacial reconstruction devices and their potential long-term
152local and systemic effects [7].
153Dr. Nadim Hallab, a keynote speaker, discussed immunologic
154responses to metal particulation due to functional wear associated
155with TMJ replacement devices, in comparison to hip and knee
156total joint replacements. Given that <1% of the >1 106 people
157per annum receiving orthopedic total joint replacement implants
158in the U.S. are not tested for metal sensitivity pre-op or at revi-
159sion, it is likely that implant-related metal sensitivity has been
160underreported and remains underestimated. However, the slow
161and continuing improvements in sensitivity testing will likely con-
162tinue to provide cumulative clinical evidence into the utility of
163metal sensitivity testing, along with greater understanding into
164how and when metal sensitivity develops [8].
165Clinical Diagnostic and Therapeutic Studies. Clinical studies
166related to the diagnosis and management of temporomandibular
167joint disorders were reported. The results of a diagnostic electro-
168myography (EMG) study from Dr. Connelly’s group demonstrated
169that temporomandibular disorder (TMD) patients had different
170muscle coordination chewing patterns in the masseter and tempo-
171ralis muscles compared to normal controls. The TMD patients
Fig. 1 Number of publications from PubMed with the key terms “TMJ” from 2006 to 2018
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172 demonstrated working-side muscle activity that was significantly
173 less than in the normal controls, possibly due to preferred side
174 chewing patterns. The authors felt these data may provide a refer-
175 ence base for further EMG studies in TMD patients [9].
176 A study was presented from Dr. Lund’s group that examined
177 the extracellular matrix (ECM) proteins in synovial tissue from
178 patients with internal derangement compared to generalized joint
179 hypermobility and normal joint mobility. While the results dem-
180 onstrated no statistically significant difference in ECM proteins
181 between generalized joint hypermobility and normal joint mobil-
182 ity, patients with internal derangement had significant differences
183 in ECM protein concentrations—indicating TMJ synovial tissue
184 deterioration. These findings may provide synovial fluid markers
185 that might aid in the diagnosis or progressive TMJ disease [10].
186 The difficulty in the differential diagnosis of TMJ chondroma-
187 tosis versus chondrosarcoma was presented by Dr. Levorova.
188 Since the treatments and prognoses of these two pathologic enti-
189 ties are completely different, surgeons and pathologists must be
190 aware of this distinction [11].
191 Therapeutically, results with the use of intra-articular platelet
192 rich plasma (PRP) in the management of TMD pain was presented
193 by Dr. Machon. PRP may effect changes in cell proliferation and
194 regulation of cellular metabolism. This study reported the 5-year
195 follow-up results after PRP injection into the joints of Wilkes IV
196 and V patients. Seven percent of the patients reported no differ-
197 ence in their pain, but 45% experienced the return of their pain
198 within 5 years. The presenter concluded that the major factor in
199 failure of PRP therapy was the duration of patient joint pain
200 before treatment. This study encouraged the important of early
201 diagnosis and management of TMJ pathology [12].
202 Biomechanics Session
203 This session provided an update on recent and ongoing biome-
204 chanical studies related to the TMJ, mainly with regard to joint
205 loading and its consequences. The first presentation, by Dr. Gallo,
206 addressed the possible mechanical cause of degenerative joint dis-
207 ease and the puzzling gender bias with women being affected by
208 TMJ disorders more often than men in patient studies. TMJ
209 dynamical loading areas were characterized by parameters associ-
210 ated with the energy density spent in the TMJ. In 200 TMJs of
211 females and males (aged 20–40 yr), the data suggested that
212 females performed mandibular movements stressing TMJ soft tis-
213 sue with a higher energy density than in males. According to Dr.
214 Gallo, this significant difference was due primarily to the smaller
215 volumes stressed in female joints compared to males. Joint incon-
216 gruity may play a role so that asymmetric mandibular movements
217 likewise increase energy density spent in TMJ soft tissues.
218 The second contribution, from Dr. Mesnard, presented a novel
219 image processing method for the characterization of cortical and
220 cancellous bone in the mandibular ramus to be used in finite ele-
221 ment method (FEM) analyses. This method was developed with
222 the aim of providing patient-tailored information for the design
223 and planning of TMJ replacement device implantation.
224 Finally, the third communication by Dr. Sagl addressed TMJ
225 modeling concepts with the aim of performing FEM analyses of
226 mechanical loading. The study presented was based on a combina-
227 tion of computed tomography (CT) and magnetic resonance imag-
228 ing (MRI), thus providing information regarding bone and soft
229 tissues. Soft tissues were studied with MRI at different mandibular
230 positions in order to detect, in particular, TMJ disk and mastica-
231 tory muscle deformations. By using Hill-type muscle [13] as well
232 as biphasic cartilage models, it was possible to investigate the
233 effects of different movement and force patterns on TMJ loading.
234 The biomechanics session presented work in progress based on
235 research performed in centers that have traditionally studied the
236 TMJ by developing pioneering methods [14–18]. New data
237 obtained on larger subject samples are providing foundational
238 data showing different loading patterns for different diagnostic
239 groups, in particular, those with myogenous and arthrogenic pain.
240However, this research needs to be closely connected to those of
241TMJ tissue biology. Indeed, previous studies have begun looking
242at soft tissue mechanics, but changes due to tissue degeneration
243are still greatly understudied. Research mimicking TMJ loading in
244live tissue and determining its biological response is still in its
245infancy and would benefit from further investigation.
246Natural-Occurring Temporomandibular Joint Damage
247in Animals Session
248In recent years, it has become clear that animals, like humans,
249develop a spectrum of naturally occurring TMJ disorders such as
250osteoarthritis (OA), ankylosis, luxation, fracture, and neoplasm
251[19–21]. Although the anatomic and physiologic features of the
252TMJ may differ between humans and animals, these naturally
253occurring diseases may have similar or identical pathogeneses to
254the disorder in humans [22]. Specifically, studying TMJ disorders
255that naturally occur in animals may elucidate not only on the
256pathogenesis of the disorder but also its response to similar thera-
257peutic interventions intended for human use. There were several
258presentations on naturally occurring TMJ disorders in domestic
259and wild animals.
260Naturally Occurring Temporomandibular Joint Osteoar-
261thritis in Domestic Dogs. Dr. Arzi presented on recent studies
262examining naturally occurring TMJ disorders in dogs and cats,
263presenting that TMJ osteoarthritis is most common in dogs when
264compared to cats [19]. Furthermore, characterization of TMJ
265osteoarthritis in dogs revealed that, as in humans, the mechanical
266properties of the TMJ disk are negatively influenced by arthritic
267conditions as the spectrum of arthritic pathological processes
268exhibited in dogs include articular surface fibrillation, subchondral
269bone defects and sclerosis, osteophyte formation, and disk perfo-
270ration [21]. From a clinical perspective, the manifestation of TMJ
271osteoarthritis in dogs is similar to humans in the sense that clinical
272symptoms may not correlate with the presence and severity of CT
273findings [19,23].
274Naturally Occurring Temporomandibular Joint Osteoar-
275thritis in Horses. The horse is a large animal model that experi-
276ences naturally occurring TMJ disorders. For example, like
277humans, horses experience an age-related degeneration in the
278form of intra-articular disk dystrophic mineralization [24]. In
279addition, as observed in dogs, cats, and human, horses exhibit
280TMJ fractures and osteoarthritis. In his presentation entitled
281“regional and disease-related differences in properties of the
282equine TMJ disease,” Dr. Derek Cissell demonstrated that natu-
283rally occurring degenerative changes in the TMJ of horses may
284impact the compressive stiffness of the TMJ disk in a region-
285dependent fashion. In addition, he demonstrated that the horse’s
286age, the region of the TMJ, and the specific degenerative changes
287may all influence the composition and mechanical properties of
288the equine TMJ disk. These results indicated that future studies
289should determine how the equine TMJ withstands mediolateral
290forces during mastication, the consequences of altered TMJ disk
291composition, and the influence of compressibility for overall joint
292function and in the pathophysiology of TMJ arthritis in horses.
293Naturally Occurring Temporomandibular Joint Osteoar-
294thritis in Wildlife. Dr. Frank Verstraete detailed TMJ arthritis in
295wildlife via a series of comprehensive studies and publications
296that examine museum specimens. The most commonly affected
297species in the western United States include the California sea
298lion (63.5%), walrus (60.5%), and the American black bear (50%)
299[25–27]. Interestingly, this particular study found that some carni-
300vores (such as the California bobcat and gray fox) did not exhibit
301TMJ arthritis [28]. In species that exhibit moderate to serve TMJ
302arthritis, it is assumed that the disease was associated with a cer-
303tain degree of discomfort and impaired function. It was concluded
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304 that, while the exact etiology or pathophysiology of TMJ arthritis
305 in wildlife remains elusive, the disease may contribute to morbid-
306 ity and mortality.
307 Since naturally occurring disease reflects the complex genetic,
308 environmental, and physiological variation present in the human
309 population, it is plausible that better understanding of TMJ disor-
310 ders in animals will lead to a better understanding of TMJ disor-
311 ders in humans, or at least reaffirm existing findings and concepts.
312 On a similar note, clinical trial-based studies utilizing naturally
313 occurring TMJ disorders as a model can be informative for trans-
314 lation of new treatment modalities.
315 Animal Models of Degeneration Session
316 The clinical presentation of pain-free TMJ osteoarthritis is often
317 of limited clinical significance. It has been recognized that up to
318 20% of the population has evidence of TMJ osteoarthritis on
319 imaging without clinical signs or symptoms of disease [29]. Fol-
320 lowing lower back pain, TMJ discomfort is the second most com-
321 mon musculoskeletal pain disorder with an associated annual cost
322 estimated at $4 billion [30]. Therefore, incorporating pain meas-
323 ures into translational models of TMJ degenerative diseases is
324 critically important.
325 As with most chronic pain conditions, centralized pain mecha-
326 nisms often have a greater contribution to the pain syndrome than
327 the initial inciting disease, making it difficult to replicate in ani-
328 mal models [31]. This interplay between centralized pain mecha-
329 nisms and the inciting disease is evident in the clinical research of
330 TMJ disease with the diagnostic criteria for TMD disease reliance
331 on both axis I characterization of joint and muscle disease and the
332 use of axis II instruments for measuring psychosocial and pain-
333 related disability [32].
334 In TMJBC 6, only one abstract and one poster specifically
335 addressed animal pain and joint disease models. Dr. Almarza’s
336 group presented a poster on whether a sudden change in occlusion
337 is associated with the emergence of hypersensitivity in the TMJ
338 area in adult male rats. These results suggest an increased sensitiv-
339 ity to noxious mechanical stimuli following altered TMJ loading.
340 An oral presentation by Megan Sperry from Dr. Winklestein’s
341 group presented an animal model of TMJ osteoarthritis and pain
342 that utilized mechanical overload to induce condyle changes and
343 pain. In this study, nine rats underwent mechanical loading of
344 their TMJ with 3.5N of force. The findings suggest hypoxia and
345 inflammation may be early contributors to pain and structural
346 changes in the rat TMJ.
347 The incorporation of pain assessment in animal TMJ disease
348 models will be important for both the study of acute-to-chronic
349 TMJ pain transition as well as the translation of potential regener-
350 ative medicine interventions to clinical care. Further research into
351 the contribution of both central pain mechanisms and peripheral
352 contributions in TMJ animal models of degeneration is urgently
353 needed to better understand the indications and limitation of medi-
354 cal and surgical management of TMJ chronic pain. Indeed, there
355 is a dearth of science on TMJ pain, and the two studies presented
356 are not the only paths to investigate TMJ pain, indicating the need
357 for more pain mechanisms to be investigated.
358 Biological Basis for Disease and Treatments Session
359 Dr. Sunil Kapila provided an in-depth presentation highlighting
360 that there are several functional and anatomic distinctions associ-
361 ated with the TMJ when compared to those of appendicular joints.
362 These distinctions may partly explain the challenges in restoring
363 the diseased TMJ to health, or in the engineering of its replace-
364 ments. First, mandibular condyle fibrocartilage develops from the
365 neural crest rather than from mesodermal origin as does hyaline
366 cartilage in appendicular joints. Second, the mandible, including
367 the condyles, is formed as a secondary cartilage as opposed to pri-
368 mary cartilage as in the formation of appendicular joints and long
369 bones [33]. Third, mandibular condylar fibrocartilage serves a
370hybrid anatomical function of being both an articular and a growth
371cartilage, which differs from the appendicular skeleton, where
372these two functions are served by articular hyaline cartilage and
373the epiphyseal growth plates, separated by an epiphysis. Finally,
374while the articular surfaces of appendicular joints are lined by
375hyaline cartilage, that of the TMJ is composed of fibrocartilage
376[34], with the mandibular condyle consisting of deeper zones of
377hyalinelike cartilage that is separated from the more fibrouslike
378superficial zone (SZ) composed of highly aligned fibers of a pro-
379liferative cellular layer [35,36]. Therefore, TMJ fibrocartilage
380contains both types I and II collagen [37], whereas the articular
381hyaline cartilage does not typically contain type I collagen [38].
382This organization of collagen fiber alignment and type provides
383the TMJ with the functional characteristic of withstanding tensile
384loading better than hyaline cartilage. As such, Dr. Kapila
385explained that the significance of these distinctions to disease ini-
386tiation and progression between the TMJ and appendicular joints
387may explain certain genetic disorders that affect every joint in the
388body while sparing the TMJ [39] as well as the unique age and
389gender distribution of TMDs [40–44].
390Dr. Kapila then presented an overview of his work on patho-
391physiologic functions of estrogens that primarily involves signal-
392ing via estrogen receptors ER-a and ER-b [45]. The
393preponderance of TMJ problems affects women and their early
394onset is during reproductive years, as opposed to similar degener-
395ative conditions in other joints that largely afflict postmenopausal
396women. These findings have led to the implication of female sex
397hormones, particularly 17-b estradiol (E2) in TMJ osteoarthritis
398[40,46]. Indirect evidence for an association between E2 and TMJ
399diseases is provided by findings of elevated serum E2 in subjects
400with TMJ disease [46,47], the presence of the ERs in the TMJ of
401females [48], and the association of ER-a polymorphisms that
402enhance ER-a levels with the prevalence and severity of TMJ OA
403[49–54]. Dr. Kapila’s ongoing studies are exploring in vivo the
404contributions of E2, ER-a and candidate matrix metalloprotei-
405nases to the targeted loss of TMJ matrices and their contribution
406to TMJ OA specifically, but not of appendicular joint OA.
407Additionally, this session highlighted work from Dr. Yadav
408Sumit’s group with three different presentations. The objective of
409their research effort was to characterize the long-term effects of
410intermittent parathyroid hormone (I-PTH) delivery on the mandib-
411ular condylar cartilage and subchondral bone, in vitro, and in
412mice. They reported that there was a significant increase in bone
413volume, tissue density, mineral deposition, tartrate resistant acid
414phosphatase activity, cell proliferation, and cartilage thickness in
415the I-PTH treated mice when compared to a control group. In their
416second presentation, they described the effects of simultaneous
417injections of the I-PTH and alendronate on the mandibular condy-
418lar cartilage and the subchondral bone in a mice model. The find-
419ings suggested that the effects of alendronate on mandibular
420condylar cartilage may be similar to the effects of I-PTH. How-
421ever, the effects of simultaneous injections of both I-PTH and
422alendronate were more pronounced in the subchondral bone. The
423final presentation aimed to determine the effects of bone morpho-
424genetic protein (BMP-2) loss of function on the cartilage and sub-
425chondral bone of the TMJ. It was found that deletion of BMP-2 in
426aggrecan-expressing cells during postnatal development may lead
427to cartilage breakdown and early development of OA.
428The works by Dr. Kapila and Dr. Sumit highlight the need to
429tailor and design treatment therapies for the TMJ differently than
430orthopedic joints. PTH based therapies are often targeted for
431osteoporosis and mainly in females. As such, there is an opportu-
432nity to discover similar links between PTH-based therapies and
433TMJ soft tissues.
434Tissue Engineering Session
435Since the first TMJBC, the group of investigators focused on
436TMJ tissue engineering has remained small. The main contribu-
437tions have come from the original organizers Dr. Athanasiou
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438 [55–58], Dr. Detamore [36,59], Dr. Jeremy Mao [60], Dr. Scott
439 Hollister [61,62], and from Dr. Almarza [63–65]. Nevertheless,
440 profound advances have been made by these researchers in the
441 engineering of both a TMJ disk and mandibular condyle. In terms
442 of the TMJ disk, it now has been shown in animal models that
443 focal defects can be repaired and heal [55], and whole disks can
444 be replaced with scaffold that remodel to become a tissue with
445 many similarities to the native TMJ disk [65]. These studies have
446 shown that both approaches are feasible for the treatment of
447 patients with clinical indications for regenerative therapies. In
448 terms of the mandibular condyle, advances in polymer gradients
449 have regenerated bone in the condyle of rabbits [59] and the soft
450 tissue of the condyle in goats [63]. Overall, these studies draw the
451 field ever closer to create a condyle-disk composite bioengineered
452 replacement implants. Despite these breakthroughs, there are still
453 concerns with the attachment of these implants and their ability to
454 withstand the early shear and torque during mandibular functional
455 loading. More importantly, as discussed elsewhere [5], the patient
456 will need to be selected carefully, as comorbid conditions could
457 play a role in healing. Further, concerns with metaplasia, ossifica-
458 tion, and angiogenesis may be considerations for specific patients.
459 At the sixth TMJBC, presentations were focused on condyle
460 regeneration, mesenchymal stem cells (MSCs) in scaffolds, and a
461 scaffold-free cell sheet for TMJ disk focal defects. Specifically,
462 for mandibular condyle regeneration, Dr. Detamore’s Team devel-
463 oped a combinational 3D printer for TMJ tissue engineering of the
464 mandibular condyle that incorporates natural materials, such as
465 devitalized cartilage, demineralized bone, hydroxyapatite, and
466 pentanoate-functionalized hyaluronic acid with polycaprolactone
467 (PCL) to create anatomically precise, patient-specific mandibular
468 condyle bioengineered replacement implants. In these 3D-printed
469 implants, priority was placed on designing both bone and cartilage
470 regions to promote cell-infiltration, with supporting preliminary
471 data presented.
472 Dr. He’s group presented a scaffold-free cell sheet technology
473 to regenerate condylar cartilage by combining bone marrow stro-
474 mal cells (BMSCs) with condylar chondrocytes. Specifically, high
475 density coculture of these two cells were tested at different ratios
476 (Chondrocyte:BMSC¼ 10:0,7:3,5:5,3:7,0:10). After 3weeks of
477 chondrogenesis by micro-environment induction, the 10:0 and 7:3
478 groups appeared to perform better than the cartilage cell sheets.
479 In another presentation by Dr. He’s group, scaffold-free carti-
480 lage cell sheets covering bone marrow mesenchymal stem cells-
481 PCL/hydroxyapatite (BMSCs-PCL/HA) scaffolds (cell sheet
482 group) were transplanted subcutaneously and intramuscularly in
483 minipigs. The biphasic scaffold group appeared to fail in regener-
484 ation because of local nonspecific inflammation led by residual
485 and degradation products of the PGA/PLA scaffold, while the cell
486 sheet group appeared to regenerate a healthy osteochondral con-
487 struct with a mature cartilage layer and closely integrated sub-
488 chondral structure.AQ9
489Dr. Helgeland presented work on explaining the effect of the
490angiogenesis inhibitor, angiostatin, on fibrocartilage formation in
491an ectopic rat-model. Collagen type-I scaffolds were divided into
492four groups: (i) scaffold only, (ii) scaffoldþBMSCs, (iii) scaf-
493foldsþ angiostatin, and (iv) scaffoldsþ angiostatinþBMSCs.
494Cell was harvested from rat femurs. One construct from each
495group was randomly, subcutaneously implanted in the dorsa of
496Lewis rats. After 2weeks, biomarkers for inflammation, IL-1a and
497IL-1b and vascularization, CD31 appeared to be down-regulated
498in constructs functionalized with angiostatin.
499Dr. Natalia Vapniarsky, from Dr. Athanasiou’s group, pre-
500sented the first public description of their recent work to develop
501an innovative surgical method—modeling disk thinning with par-
502tial perforation in a minipig. Specifically, they designed and tested
503a surgical technique for the implantation and stabilization of the
504engineered tissue in situ, and tested in vivo the efficacy of this
505tissue-engineered construct to regenerate surgically created TMJ
506disk defects. As histological evaluation demonstrated that this
507implantation method resulted in more complete TMJ disk defect
508closure than in the untreated control TMJ disk defects. The study
509implantation method induced the formation of fibrous connective
510repair tissue that filled the TMJ disk defect and this repair tissue
511was significantly stiffer in tension than similar tissue in the
512untreated control TMJ disk defects [55].
513Dr. Embree’s group presented their work on TMJ fibrocartilage
514stem cells (FCSCs) located below the mandibular condyle SZ,
515which can self-organize and can regenerate cartilage and bone. In
516the FCSCs, Wnt/b-catenin signaling inhibits skeletal stem fate to
517differentiate into chondrocytes and over activation leads to OA,
518but with the addition of a Wnt inhibitor the FCSC population is
519maintained and the fibrocartilage is repaired. The group is looking
520to find the markers that define the TMJ FCSC population and their
521functional role in differentiation, proliferation, and progression of
522TMDs.
523The current work on TMJ tissue engineering is cutting edge and
524exciting. However, the small market for TMJ disease management
525options and devices, compared to orthopedics, presents a barrier
526to translation. Other technical barriers are also present, such as the
527efficacy of technologies in a degenerated joint, patient to patient
528variability, etc. Nevertheless, when these technical challenges are
529solved, there will always be a “valley of death” in funding to
530translate TMJ technologies due to the small market. Significant
531funding will be required from industry partners, private donors,
532foundations or the NIH (e.g., R01, SBIR/STTR) to derisk these
533technologies for translation to clinicians and their patients.
534Discussion
535After six TMJ Bioengineering Conferences, spanning more
536than 12 years, it is clear that there is a small, but growing and
537dedicated core of TMJ investigators. This group of investigators
Fig. 2 Number of R01 funded projects from NIH Reporter with the key terms TMJ from 2006 to 2018
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538 have been successful in carrying out many of the directives put
539 forth from the first conference [1], including: Patient specific data,
540 such as metal allergies; more detailed mechanical models of the
541 joint; in-depth studies of the naturally occurring TMJ damage in
542 animals; more biological differences in the TMJ between the
543 sexes and between the TMJ and other joints; biological therapies
544 and mechanisms of disease; and in vivo tissue engineering efforts.
545 In the discussions during the conference, a lack of standardized
546 research methodologies became apparent. For example, a standard
547 scale to describe the amount of joint damage on histology, such as
548 the OARSI histopathology scale used for cartilage OA, needs to
549 be used as-is or adapted to the TMJ. This scale goes from 0 (pris-
550 tine) to 6 (full cartilage loss). While the scale can be directly
551 applied to the TMJ condyle, it will have to be modified to describe
552 damage to the disk. Another area of standardization could be
553 mechanical testing, such as displacing at the same percent strain
554 rate to the same strain step for evaluating engineered tissues or
555 establishing target loading values for implanted bone regions for
556 mandibular condyle scaffolds. These changes should be relatively
557 easy to implement as the community is still small and cohesive.
558 Furthermore, standardized outcome measures would assist new-
559 comers to TMJ research in comparing their technologies to the
560 established benchmarks.
561 Another major topic of discussion was the appropriate target
562 audience for TMJ research, and the sustainability of current
563 efforts. TMJ research is not prominent at the ORS, and in general
564 appears to be more prominent in the dental research community.
565 TMJ podium sessions at the AADR highlight pain, biomechanics,
566 and tissue engineering research. However, TMJ research no lon-
567 ger has a focused research group base at AADR and IADR but is
568 instead spread over many research groups in an ad hoc fashion.
569 As an example, formerly there was the IADR “Neuroscience/
570 TMJ” scientific group, now it is only titled as the “Neuroscience”
571 group. There was additional concern raised about current Federal
572 funding. TMJ grants in tissue engineering, TMJ biomechanics,
573 and TMJ replacement devices are assigned to study sections that
574 do not typically focus on TMJ research, which may make it diffi-
575 cult for reviewers to truly assess the significance and innovation
576 of the proposed work. This can be seen by a decreasing trend of
577 NIH R01 funded projects on TMJ from 2006 to 2018 and almost a
578 50% drop from 2009 to 2018 (Fig. 2). Furthermore, the low num-
579 ber of NIH R21 projects, with an average of less than two projects
580 per year from 2013 to 2018, indicates a high barrier for entry of
581 new investigators into the TMJ field and the development of new
582 lines of research (Fig. 3).AQ10
583 As the TMJ Bioengineering Conferences move forward, it is
584 hoped that interdisciplinary research continues to grow to bring
585 new diagnostics and therapies to TMJ patients. The group sees
586 many opportunities for the future. First, initiatives at the NIDCR
587 for funding TMJ research have arguably been largely focused on
588pain as highlighted in “The orofacial pain: prospective evaluation
589and risk assessment” studies [66–68]. Future request for applica-
590tions (e.g., requests for applications) should go beyond pain, such
591as ones that will study joint damage and regeneration, which com-
592plements the current NIDCR initiatives. Second, to grow the field,
593more training grants are needed for graduate students and fellows
594to become engaged in TMJ science. Third, since TMJ tissue engi-
595neering solutions have a small market when compared to orthope-
596dic joints, there is a potential to partner with the Food and Drug
597Administration for developing translational bioengineered solu-
598tions. Lastly, there is room to grow the pool of TMJ experts on
599grant review panels, to the point that a critical mass of researchers
600with significant knowledge and experience is able to assess the
601significance and impact of groundbreaking TMJ research. The
602past 12 years have seen important new contributions in the TMJ
603Bioengineering Community, with tremendous opportunity in the
604next dozen years ahead.
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